DNA Synthesis Market Size, Share and Trends 2026 to 2035

What is DNA Synthesis Market Size?

The global DNA synthesis market size accounted for USD 5.93 billion in 2025 and is predicted to increase from USD 7.08 billion in 2026 to approximately USD 34.39 billion by 2035, expanding at a CAGR of 19.22% from 2026 to 2035. Ongoing growth of genre therapies is the key factor driving market growth. Also, innovations in CRISPR-Cas9 gene editing, coupled with the growing demand for personalized medicine, can fuel market growth further.

Market Highlights

• North America generated more than 40% of revenue share in 2025.
• By Service, the oligonucleotide synthesis segment captured the maximum market share of around 39.98% in 2025.
• By Application, the research and development (R&D) contributed the highest market share of around 44.96% in 2025.
• By End-User, the biopharmaceutical companies segment captured the biggest market share of 42.03% in 2025.

Market Overview

The DNA synthesis market refers to the industry that is involved in the production and sale of synthetic DNA, which is also known as artificial or engineered DNA. Synthetic DNA is created by chemical synthesis, rather than by natural biological processes, and is used in a wide range of applications, including genetic research, drug discovery, and the development of new biotechnology products. The DNA synthesis market is expected to grow in the coming years, as advances in synthetic biology and gene editing techniques drive the development of new applications for synthetic DNA.

The market is highly competitive and dominated by a few key players such as Twist Bioscience Corporation, Integrated DNA Technologies, Eurofins Scientific, and GenScript Biotech Corporation. These companies are constantly investing in R&D to develop new technologies and expand their product portfolios, which is expected to drive the growth of the market in the coming years.

How is AI Influencing the DNA Synthesis Industry?

Artificial Intelligence is profoundly changing the DNA synthesis market by allowing advanced innovation, driving operational efficiency, and thus, supporting smarter decision-making. AI is rearranging the strategic direction of the market by uncovering meaningful insights and identifying the latest trends that drive more informed business strategies.

Its impact spans personalized customer interactions and faster product development cycles, along with streamlined process optimization. From predictive maintenance as well as quality assurance to real-time data monitoring, AI now strengthens operational reliability and guarantees consistent performance.

DNA Synthesis Market Growth Factors

• The extensive adoption of CRISPR-Cas technologies and molecular biology research needs a high-quality, custom-designed guide for RNAs and synthetic DNA constructs, leading to market growth.
• Advancements in DNA synthesis methods, especially the transition from conventional chemical approaches to enzymatic DNA printing, enable more rapid turnaround times and longer, more complex DNA constructs with fewer errors.
• Regulatory bodies are substantially growing the annual approval rate for gene therapies, fuelling commercial biopharma investments directly into synthesis pipelines, driving market growth shortly.
• Pharmaceutical corporations are heavily divesting from costly in-house printing infrastructure, favouring outsourcing synthesis to hyper-automated contract development.
• Advances in DNA synthesis technology have enabled faster and more efficient synthesis of DNA sequences. This has led to increased demand for DNA synthesis services and products. For instance, companies such as Twist Bioscience and GenScript are investing heavily in developing advanced DNA synthesis platforms that can create synthetic genes up to several thousand base pairs in length.
• Many governments around the world have been investing heavily in genomics research, which has increased the demand for DNA synthesis services and products.
• The use of synthetic DNA in personalized medicine is an emerging field. With the increasing focus on personalized medicine, the demand for custom DNA sequences and synthetic genes is expected to grow. Synthetic DNA can be used to create personalized treatments for individuals based on their genetic makeup, which can improve the efficacy of treatments and reduce the risk of side effects. For instance, three next-generation sequencing (NGS) targeted enrichment panels have been released, according to a joint announcement by Twist Bioscience Corporation and Centogene N.V., to aid in the study of uncommon diseases, hereditary cancers, and diagnostics.

Market Scope

Market Dynamics

Drivers

Increasing demand for synthetic genes and DNA sequences

With advancements in synthetic biology and genetic engineering, the demand for synthetic genes and DNA sequences has been increasing rapidly. Synthetic genes and DNA sequences can be used to create new enzymes, proteins, and other molecules with specific properties, which can be used in various applications. Moreover, advances in DNA synthesis technology have made it easier and cheaper to synthesize genes and DNA sequences. This has led to an increase in demand for synthetic genes and DNA sequences, as well as a decrease in the cost of DNA synthesis. These synthetic genes and DNA sequences are used in a variety of applications, such as gene therapy, drug development, and agricultural biotechnology. For instance, Evonetix describes DNA synthesizer technology that will speed development across multiple therapeutic modalities.

Growing Applications in the Agriculture and Food Industry

DNA synthesis is used in agriculture for the improvement of crops, including the development of genetically modified organisms (GMOs), gene stacking, and trait introgression. DNA synthesis is used to engineer genetically modified (GM) crops with desirable traits, such as increased yield, enhanced disease resistance, improved nutritional content, and tolerance to environmental stresses. By synthesizing specific DNA sequences and introducing them into plant genomes, scientists develop crops with targeted genetic modifications. Furthermore, many farming operations such as crop cultivation cause alterations in DNA gene expression. DNA technology is used to detect the changes in levels that assist in the regulation of crop development and growth.

Additionally, it is also utilized in the food industry to produce enzymes, flavors, and food additives through metabolic engineering approaches. DNA synthesis is used in the development of functional foods which are enriched with specific nutrients and proactive or bioactive compounds. DNA synthesis enables the development of synthetic DNA standards for use in food safety testing. These standards are able to be used to verify the accuracy and reliability of molecular detection methods, such as polymerase chain reaction (PCR), in detecting allergens, contaminants, and genetically modified organisms (GMOs) in food products. Synthetic DNA is also used to develop reference materials for quality control and proficiency testing programs. DNA synthesis contributes to sustainable agriculture practices. For instance, synthetic DNA is used to engineer microorganisms capable of fixing atmospheric nitrogen, reducing the need for synthetic fertilizers. Along with this, DNA synthesis decreases the use of chemical pesticides, which impact the environment by developing biopesticides, which are derived from natural sources.

Technological Advancements

Various technological advancements are going on in the DNA synthesis market. Investors and firms are mainly benefiting from the advancement in DNA synthesis. These innovations are made to expand the capabilities and reduce the cost. Some high-throughput DNA synthesis platforms are developed to develop DNA at a larger scale and faster rate. Next-generation synthesis methods, such as microarray-based synthesis, massively parallel synthesis, and enzymatic synthesis, have enabled high-throughput production of DNA sequences. The platforms produce thousands of DNA sequences simultaneously. Additionally, the current DNA synthesis technologies include error correction techniques to improve the accuracy of DNA sequences. For instance, methods such as overlap assembly assist in the removal or elimination of errors and increase reliability.

Furthermore, Next-Generation Sequencing technologies have changed DNA synthesis by enabling high-throughput sequencing at a lower price. Along with this, these sequencing platforms have improved the accuracy and speed of DNA synthesis, which accelerates research in genomics. Numerous DNA assembly techniques, such as Gibson assembly, have emerged to accelerate the construction of larger DNA sequences and genetic structures. Along with this, the advancement in DNA synthesis has also contributed to the development of DNA nanotechnology. This helps in drug delivery systems, biosensors, and nanoelectronics.

Some technologies, such as CRISPR technology, provide better precision in gene editing tools which are able to alter DNA in animals, bacteria, and plants. This is highly efficient in implementing and identifying therapies for diseases such as Alzheimer, cancer, etc. Furthermore, DNA has the ability to encode vast amounts of data in the form of dense groups of oligonucleotides. The advanced technology CRISPR uses DNA synthesis to develop modified DNA which helps to correct genetic defects. Along with this, DNA synthesis is used in other fields like drug development, agriculture, research, and biotechnology.

Increasing Accessibility

DNA synthesis is an artificial construction of DNA molecules using laboratory techniques. DNA sequencing has become an important tool in various sectors, such as molecular biology, biotechnology, genetic engineering, and synthetic biology. DNA synthesis technology is easily accessible and is available to a broad range of customers or users, such as researchers, scientists, and others. DNA sequencing develops user-friendly platforms and software for ordering and designing DNA. Along with this, open-source initiatives and protocols are also anticipated to fuel the market of DNA synthesis. Various training programs, workshops, and educational resources are provided on DNA synthesis techniques which are able to empower researchers and scientists with skills to utilize DNA synthesis.

Furthermore, there is continuous advancement in DNA synthesis technologies, such as higher throughput, which leads to a reduction in cost. These platforms synthesize multiple DNA sequences simultaneously, reducing the time required for large-scale DNA synthesis. For instance, a variety of next-generation sequencing and DNA microarray technologies have been developed to significantly increase the efficiency of DNA synthesis. Additionally, the government is providing financial support and research funding to scientists to promote more projects utilizing DNA synthesis technology. A variety of transgenic techniques are used to enhance the quality and yield of synthetic DNA.

Restraints

• Cost - DNA synthesis can be a relatively expensive process, which can make it difficult for researchers with limited budgets to access the technology.
• Errors - Although DNA synthesis technology has improved greatly in recent years, errors can still occur during the process. This can lead to inaccurate or unreliable results, which can be problematic for researchers.
• Safety concerns - There is always a risk of accidental release of synthetic DNA or the creation of dangerous pathogens. This requires strict safety protocols to be in place, which can be time-consuming and costly to implement.

High Cost

DNA synthesis involves complex chemical reactions and requires advanced equipment. Various steps are involved in the synthesis process, such as nucleotide coupling, purification, and deprotection. These multiple steps are time-consuming and require a large number of resources. Along with this, the DNA synthesis process is dependent on the availability of high-quality raw materials such as reagents and enzymes. The cost of raw materials contributes to the overall cost of the process. Additionally, continuous advancements in DNA synthesis technologies require substantial investment in research and development (R&D). Companies invest heavily in improving synthesis methods, increasing yield, and developing new chemistries, all of which add to the cost.

The cost per base pair of synthesized DNA decreases with scale. Larger-scale production is able to take advantage of economies of scale, reducing the cost per unit. However, smaller-scale custom synthesis or specialized applications may still incur higher costs due to lower volume and more specific requirements. Furthermore, enzymatic DNA synthesis is still in its initial stage, and optimization is essential before use. A deoxynucleotidyl transferase (TdT) method is commonly used to improve the procedure and avoid the production of waste. However, the low accuracy, as well as the high cost associated with this method, acts as a barrier in in-vitro DNA synthesis. Along with this, it is a complex procedure as more reagents are added to develop the target sequence.

Synthesis Errors and Quality Control

The process of DNA synthesis is not free of errors, and errors might take place. These errors result in the production of DNA sequences that differ from the intended design, which leads to inaccuracies in the final product. Maintaining high-quality control standards and minimizing synthesis errors are ongoing hindrances for DNA synthesis companies. Ensuring accurate synthesis becomes necessary, especially for applications like gene therapy or DNA-based diagnostics. Manufacturers verify the accuracy of synthesized DNA sequences by performing DNA sequencing. This involves comparing the synthesized sequence with the intended design to identify any discrepancies. The quantity of synthesized DNA is determined using various methods such as UV spectroscopy or quantitative PCR (qPCR). This ensures that the desired amount of DNA is synthesized. In addition to sequence verification, manufacturers may perform functional tests to assess the performance of synthesized DNA. These tests involve cloning the DNA into a host organism and evaluating its functionality in various assays. Even though purification is done, some errors which remain in the DNA synthesis process will be carried out during the assembly procedure. Errors may also take place due to mis-hybridization or polymerase elongation.

Opportunities

• Forensic Science - Synthetic biology involves the creation of new biological systems using synthetic DNA. This field is rapidly expanding, and the demand for synthetic DNA for synthetic biological applications is expected to increase in the coming years. Synthetic DNA can be used in forensic science to create synthetic DNA samples that can be used to calibrate forensic equipment and validate analytical methods. The demand for synthetic DNA in forensic science is expected to increase as the technology becomes more widely used.
• Gene Therapy - The development of gene therapies is a growing field, which requires the synthesis of DNA for the delivery of therapeutic genes. The demand for synthetic DNA for gene therapy is expected to increase significantly in the coming years.
• Drug Discovery - Synthetic DNA is widely used in the development of new drugs. Pharmaceutical companies use synthetic DNA to create libraries of compounds, which can be screened for potential therapeutic applications.

Growing Demand for Personalized Medicine

DNA synthesis assists in the development of life-saving drugs. Personalized medicine is a drug that is specific therapeutics suited to a patient. It is based on pharmacogenomics, pharmacogenetics, pharmacometabolomic, and pharmacoproteomic information. It helps in enhancing the early detection and prevention of various disorders and monitoring therapy. Personalized medicine is also defined as improved healthcare by implementing preventive medicine, rational drug development, monitoring of therapy, and early detection of disease. Scientists are using gene synthesis to develop personalized medicine for patients with specific genetic variations and mutations. DNA synthesis plays a vital role in the development of DNA-based diagnostic tests. These tests utilize synthetic DNA probes or primers to detect specific genetic sequences associated with diseases, pathogens, or genetic variations. The increasing demand for personalized medicine and precision diagnostics has driven the growth of DNA-based diagnostics.

Furthermore, the development of gene therapies is a growing field that requires the synthesis of DNA for the delivery of therapeutic genes. The need for synthetic DNA for gene therapy is anticipated to increase considerably during the forecasted years. Synthetic DNA is utilized in forensic science to develop synthetic DNA samples that are able to be used to validate analytical procedures and calibrate forensic equipment. The demand for DNA synthesis in forensic science is predicted to rise as the technology is more widely used. Researchers are using gene synthesis to design custom DNA chains that are used to design personalized treatments for patients with specific genetic variations or mutations.

Segments Insights

Service Insights

Why did the Oligonucleotide Synthesis Segment Dominated the DNA Synthesis Market?

The oligonucleotide synthesis segment dominated the market with the largest share in 2025. The dominance of the segment can be attributed to the increasing trend towards outsourcing specialized synthesis workflows along with the innovations in synthetic biology. In addition, market players are using lab automation, microfluidics, and AI-assisted design to minimize synthesis costs while preserving high purity. Oligonucleotides are short, synthetic sequences of nucleic acids that act as foundational building blocks for genetic testing.

The gene synthesis segment is expected to grow at the fastest CAGR over the forecast period. The growth of the segment can be credited to the growing need for synthetic biology, cutting-edge CRISPR gene editing, and personalized medicines. The integration of artificial intelligence algorithms into gene design and sequence optimization is significantly advancing manufacturing capabilities, impacting positive market growth soon.

DNA Synthesis Market Revenue, by Service, 2022-2024 (USD Million)

Application Insights

What Made Research & Development the Leading Segment in the DNA Synthesis Market?

The research & development segment dominated the market with the largest share in 2025. The dominance of the segment can be linked to the growing demand for custom gene constructs in precision medicine, along with innovations in CRISPR gene-editing technologies. Additionally, advancements in metabolic engineering, bio-based materials, and synthetic biology are increasingly dependent on customized gene libraries and large-scale DNA assembly.

The diagnostic segment is expected to grow at the fastest CAGR over the forecast period. The growth of the segment can be driven by an increasing need for molecular testing, extensive adoption of personalized medicine, and growing investment in biotechnology research. Furthermore, the ongoing pursuit of accelerated and highly precise sequencing methodologies for the early detection of disease continues to drive segment growth soon.

DNA Synthesis Market Revenue, by Application, 2022-2024 (USD Million)

End-User Insights

The Biopharmaceutical Segment Dominated the DNA Synthesis Market?

The biopharmaceutical companies segment dominated the market with the largest share in 2025. The dominance of the segment is owing to the ongoing growth of mRNA vaccines and increasing approvals for cell and gene therapies. Major industry leaders leverage high-throughput, silicon-based DNA synthesis, specializing in custom antibody production and biopharma licensing.

The contract research organizations segment is expected to grow at the fastest CAGR during the projected period. The growth of the segment is due to the increasing need for specialized manufacturing and the surge in biopharma outsourcing. Furthermore, a significant expansion in clinical pipelines for cell therapies, gene therapies, and DNA-based vaccines has generated a critical demand for high-precision, Good Manufacturing Practice (GMP)-grade synthetic DNA.

Regional Insights

What Factors Made North America the Dominant Region in the Market?

North America dominated the market with the largest share in 2025. The dominance of the region can be attributed to the increasing need for personalized medicine and customized therapies for genetic and rare diseases, which depend heavily on oligonucleotide synthesis. In addition, substantial public funding and targeted grants from governmental institutions, such as the National Institutes of Health (NIH), serve as the primary driver for advancements in genomics research and synthetic biology.

U.S. Market Trends

The U.S. dominated the market in 2025 owing to robust investments in synthetic biology, gene therapies, and precision medicine. Also, extensive partnerships between these corporations and premier research institutions accelerate the commercialization of DNA-based therapeutics further.

U.S. DNA Synthesis Market Size and Growth 2026 to 2035

The U.S. DNA synthesis market size was exhibited at USD 1.90 billion in 2025 and is projected to be worth around USD 10.66 billion by 2035, growing at a CAGR of 18.82% from 2026 to 2035

This has led to an increase in the number of companies offering DNA synthesis services and products in the region. The government of North America has implemented several policies to support the development of the biotech industry, including DNA synthesis. This has created a favorable regulatory environment for the growth of the DNA synthesis market in the region.

Which Factors Made Asia Pacific a fastest Growing Region in the Market?

Asia Pacific is expected to grow at the fastest CAGR over the forecast period. The growth of the region can be credited to the increasing demand for personalized medicine, an increase in pharmaceutical research, and government biotech funding. Reduced operational expenses and an extensive talent pool of skilled scientists are driving global biotechnology companies to establish manufacturing facilities and outsource services to the region.

China Market Trends

In the Asia Pacific, China led the market due to expanding synthetic biology applications and ongoing investment in genome sequencing technologies. Moreover, China hosts an extensive pool of skilled researchers and cost-effective manufacturing facilities, hence attracting global biotechnology firms to outsource their drug discovery and development processes.

• North America DNA synthesis market size was valued at USD 1.4 billion in 2022 and it is expected to hit at a CAGR of 19.1% from 2023 to 2032.
• Europe DNA synthesis market size was estimated at USD 1.01 billion in 2022 and it is poised to grow at a CAGR of 19.4% from 2023 to 2032.
• Asia Pacific DNA synthesis market size was valued at USD 1 billion in 2022 and it is predicted to reach at a CAGR of 20.5% from 2023 to 2032.

Which Factors Made Europe a Significantly Growing Region in the Market?

Europe is expected to grow at a significant CAGR over the forecast period. The growth of the region can be linked to the surge in investment in synthetic biology and growing clinical trials for advanced therapies. In addition, the ongoing expansion of molecular diagnostic capabilities throughout European clinical networks sustains a robust and expanding pipeline for synthetic fragment production.

Germany Market Trends

In Europe, Germany led the market due to growing biotechnology, pharmaceutical and synthetic biology sectors. Also, Germany features an extensive infrastructure of premier academic institutions, biobanks, and leading pharmaceutical enterprises. Robust local trends emphasizing sustainable, waste-reducing manufacturing methods can lead to market growth soon.

Latin America Market Trends

Latin America held a considerable share of the market in 2025. The growth of the region can be driven by increasing healthcare expenditure and advanced laboratory facilities which allow a surge in adoption of molecular diagnostic technologies. Moreover, the transition towards enzymatic synthesis platforms is unlocking new revenue streams by lowering manufacturing costs, enabling the production of longer sequences, and reducing overall turnaround times.

Brazil Market Trends

The growth of the country in the region can be attributed to the growing utilization of synthetic biology and gene editing technologies, such as CRISPR-Cas9. Additionally, the growing integration of algorithms to identify optimal gene constructs is enhancing both the velocity and precision of projects using DNA molecules.

Middle East and Africa Market Trends

The Middle East & Africa held a notable share of the market in 2025. The growth of the region can be attributed to the ongoing regional shift towards rare disease diagnostics, personalized therapeutics, and targeted cancer treatments. Furthermore, medical centers are increasingly using custom DNA sequences to develop targeted therapies tailored to the genetic profiles of regional populations, driving regional growth soon.

Saudi Arabia Market Trends

The growth of the market in the country can be fuelled by innovations in clinical trial pipelines in cell and gene therapies and significant government funding initiatives. Moreover, the Saudi government has established comprehensive regulatory frameworks, funding mechanisms, and tax incentives designed to attract international life sciences and biomanufacturing enterprises.

Value Chain Analysis for the DNA Synthesis Market

• R&D : By developing faster, more accurate, and cost-effective methods to create artificial genetic material.
  Key Players: Twist Bioscience, GenScript Biotech Corporation, Integrated DNA Technologies, Inc.
  
• Clinical Trials and Regulatory Approvals : It acts as a vital driver for the DNA synthesis market by changing research-grade synthetic DNA into standardized, high-quality, and scalable components for therapeutics, mainly in gene therapy, vaccines, and personalized medicine.
  Key Players: Integrated DNA Technologies, Inc., GenScript Biotech Corporation, Eurofins Scientific
  

Competitive Landscape

The global DNA synthesis market is highly competitive and increasingly expanding, fueled by the growing need for gene therapies, personalized medicine, and synthetic biology. Market leaders and emerging enterprises compete vigorously by utilizing automation, minimizing error rates, and accelerating turnaround times for customized DNA constructs. Major market players include Thermo Fisher Scientific (through its automated GeneArt division), Integrated DNA Technologies (IDT) (a subsidiary of Danaher Corporation), and GenScript Biotech Corporation.

Biotechnology companies are increasingly transitioning from traditional chemical phosphoramidite approaches to enzymatic DNA synthesis to improve production. This shift enables the creation of longer, more complex sequences while accelerating turnaround times.

Top Companies in the DNA Synthesis Market & their offerings

• IBA GmbH: IBA GmbH provides specialized high-quality custom DNA as well as RNA oligonucleotide synthesis for research and diagnostic applications. Their portfolio includes labeled, along with modified nucleic acids for PCR, FRET, and, in partnership with RiNA GmbH, custom DNA/RNA aptamers for diagnostics, targeted therapy, and imaging.
• Twist Bioscience: Twist Bioscience provides a high-throughput DNA synthesis platform utilizing a proprietary silicon-based method to write DNA, producing, for example, 9,600 genes on a single chip. They provide, for instance, custom NGS-verified clonal genes, oligo pools, gene fragments, and antibody libraries for applications in drug discovery and diagnostics, together with data storage.

Other DNA Synthesis Market Companies

• LGC Biosearch Technologie
• Bioneer Corporation
• Thermo Fisher Scientific, Inc.
• Eton Bioscience
• Quintara Biosciences
• Eurofins Scientific
• Integrated DNA Technologies, Inc
• GenScript Biotech Corporation

Recent Developments

• In April 2026, Twist Bioscience Corporation expanded its clonal gene portfolio with the early access launch of Complex Genes, enabling the synthesis of structurally intricate protein sequences. The company reported an enhanced operational capacity, now facilitating approximately 99.5% of clonal gene orders and 99.9% of all DNA products. (Source: https://www.investing.com)
  
• On 12th Nov 2024, Ansa biotechnologies sets a new standard in long, complex DNA. A technology pairs with groundbreaking complex DNA synthesis platform. Ansa's enzymatic idea has eliminated the need for harsh chemicals.
• On 13th May 2024, Twist Bioscience launched multiplexed gene fragments to enable high-throughput screening applications. The chemistry enables direct synthesis of up to 500 bp double-stranded fragments. It has no limit on the sequence number.
• On 6th Aug 2024, Integrated DNA technologies bolsters synthetic biology portfolio with launch of rapid genes and significant upgrades to gene synthesis offerings. Advanced technology provides solutions to advance drugs and fastens turnaround times.

Segments Covered in the Report

By Service

• Oligonucleotide Synthesis
  • Custom Oligonucleotide Synthesis
  • Pre-designed Oligonucleotide Synthesis
• Gene Synthesis

By Application

• Research and Development
• Therapeutics
• Diagnostic

By End-User

• Biopharmaceutical Companies
• Academic and Research Institutes
• Contract Research Organizations

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa